Skip to main content
. 2020 Oct 15;8:594226. doi: 10.3389/fcell.2020.594226

FIGURE 2.

FIGURE 2

Robust proliferation of human iPSC-CMs is promoted by WNT signaling activation. (A) Typical morphology of human iPSC-CMs stained with antibodies against cardiac troponin T (TNNT2, green) and α-actinin (red). Nuclei were counterstained with DAPI (blue). (B) Zoom-in sarcomere structure of human iPSC-CMs with intercalated TNNT2 (green) and α-actinin (red). (C,D) Robust proliferation of human iPSC-CMs from Day 1 (D1,C) to D7 (D) in the presence of 2 μM of a WNT activator (CHIR99021). (E,F) Dramatic increase of dividing CMs is propelled by CHIR99021. Cells were stained with Ki67 (green) and TNNT2 (red). Nuclei were counterstained with DAPI (blue). Double positive cells (indicated by white arrows) are dividing cardiomyocytes. The percentage of Ki67+ TNNT2+ cells is increased in CHIR99021-treated iPSC-CMs (F) compared to the controls (E). Scale bars: 10 μm (B); 100 μm (A,E,F); 200 μm (C,D).